Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
Clinical trial NCT02654990 · COMPLETED
Trial details
- NCT number
- NCT02654990
- Sponsor
- pharmaand GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-27
- Primary completion
- 2019-10-18
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.